Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in spontaneous intracerebral hemorrhage
IRCT20191014045103N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: Intracerebral hematoma non-progression, Mortality and 1 more. Started Dec 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20191014045103N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191014045103N1.